Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

International Flavors & Fragrances Inc.

Start price
Target price
Perf. (%)
€93.04
08.02.21
-
08.02.22
-
08.02.21

Risky Investment
BioNTech SE ADR

Start price
Target price
Perf. (%)
€96.99
08.02.21
-
08.02.22
2.46%
08.02.21

Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
buy
Nokia Corp.

Start price
Target price
Perf. (%)
€3.53
07.02.21
-
-2.99%
21.03.21

Risky Investment
buy
Sify Technologies Ltd ADR

Start price
Target price
Perf. (%)
€2.36
07.02.21
€3.80
29.10.24
-18.64%
05.07.22

buy
Zynga Inc.

Start price
Target price
Perf. (%)
€9.00
07.02.21
€10.00
07.02.22
-30.00%
01.11.21

Capable Management
Very low/no dividend yield expected
Risky balance sheet
Few uniques
buy
CENIT AG

Start price
Target price
Perf. (%)
€14.35
07.02.21
€14.00
07.02.22
-7.67%
08.02.22

Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Good rating
Inpixon

Start price
Target price
Perf. (%)
€111.75
07.02.21
€22.50
07.02.22
-74.54%
08.02.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Stericycle Inc.

Start price
Target price
Perf. (%)
€57.18
07.02.21
-
07.02.22
5.35%
21.06.21

Probably not worthwhile Investment
Low dividend yield expected
buy
Formycon AG

Start price
Target price
Perf. (%)
€67.40
07.02.21
€80.00
07.02.22
-20.03%
08.02.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High valuation
Low dividend yield expected
buy
Millennial Lithium Corp

Start price
Target price
Perf. (%)
€2.80
07.02.21
€3.00
07.02.22
-17.17%
04.08.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Very low/no dividend yield expected
Borussia Dortmund

Start price
Target price
Perf. (%)
€5.12
07.02.21
€4.00
07.02.22
4.49%
20.02.21

Revenue decline > 20% expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Little Investments for future growth
buy
Seelos Therapeutics Inc.

Start price
Target price
Perf. (%)
€2.88
07.02.21
€5.00
07.02.22
-66.49%
08.02.22

Could be worthwhile Investment >10% per year
Top 10 in its market
buy
Inpixon

Start price
Target price
Perf. (%)
€111.75
07.02.21
€225.00
07.02.22
-74.54%
08.02.22

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
buy
Marin Software

Start price
Target price
Perf. (%)
€2.30
07.02.21
€10.00
07.02.22
20.00%
08.02.22

Could be very worthwhile Investment >20% year
Very small cyclical dependencies
buy
Anglo American Platinum

Start price
Target price
Perf. (%)
€89.40
07.02.21
€90.00
07.02.22
15.21%
08.02.22

Could be worthwhile Investment >10% per year
buy
Nouveau Monde Graphite Inc

Start price
Target price
Perf. (%)
€11.00
07.02.21
€10.00
07.02.22
-45.00%
08.02.22

Could be very worthwhile Investment >20% year
Top 10 in its market
Known brand
buy
Largo Inc.

Start price
Target price
Perf. (%)
€12.12
07.02.21
€20.00
07.02.22
-37.06%
08.02.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Lithium Americas Corp.

Start price
Target price
Perf. (%)
€16.04
07.02.21
€20.00
07.02.22
48.32%
08.02.22

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
buy
Element 25 Ltd.

Start price
Target price
Perf. (%)
€1.08
07.02.21
€2.00
07.02.22
-25.56%
08.02.22

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
American Lithium Corp

Start price
Target price
Perf. (%)
€1.91
07.02.21
€2.00
07.02.22
20.45%
08.02.22

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
buy
Moderna Inc.

Start price
Target price
Perf. (%)
€143.50
07.02.21
-
07.02.22
0.42%
20.02.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Shop Apotheke Europe NV

Start price
Target price
Perf. (%)
€239.50
07.02.21
-
07.02.22
-38.71%
19.11.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
High dividend yield expected
Innovative
buy
7C Solarparken

Start price
Target price
Perf. (%)
€4.69
07.02.21
€9.00
07.02.22
-11.94%
08.02.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
H&R GmbH & Co. KGaA

Start price
Target price
Perf. (%)
€5.93
07.02.21
€9.00
07.02.22
28.84%
08.02.22

Good culture
Revenue growth >5% per year expected
Capable Management
Little innovation
buy
Mobotix AG

Start price
Target price
Perf. (%)
€7.70
07.02.21
€11.00
07.02.22
-38.70%
08.02.22

Could be worthwhile Investment >10% per year
Fair valuation
Management is a major shareholder
Capable Management